These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20076796)

  • 1. Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.
    Mistur R; Mosconi L; Santi SD; Guzman M; Li Y; Tsui W; de Leon MJ
    J Clin Neurol; 2009 Dec; 5(4):153-66. PubMed ID: 20076796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.
    Mosconi L; Pupi A; De Leon MJ
    Ann N Y Acad Sci; 2008 Dec; 1147():180-95. PubMed ID: 19076441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.
    Mosconi L; Berti V; Glodzik L; Pupi A; De Santi S; de Leon MJ
    J Alzheimers Dis; 2010; 20(3):843-54. PubMed ID: 20182025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.
    Mosconi L
    Clin Transl Imaging; 2013 Aug; 1(4):. PubMed ID: 24409422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
    Mosconi L; Mistur R; Switalski R; Tsui WH; Glodzik L; Li Y; Pirraglia E; De Santi S; Reisberg B; Wisniewski T; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):811-22. PubMed ID: 19142633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
    de Leon MJ; Mosconi L; Blennow K; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Tsui W; Saint Louis LA; Sobanska L; Brys M; Li Y; Rich K; Rinne J; Rusinek H
    Ann N Y Acad Sci; 2007 Feb; 1097():114-45. PubMed ID: 17413016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
    Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
    Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of Alzheimer's disease using neuroimaging.
    Mosconi L; Brys M; Glodzik-Sobanska L; De Santi S; Rusinek H; de Leon MJ
    Exp Gerontol; 2007; 42(1-2):129-38. PubMed ID: 16839732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of CSF Neurogranin and
    Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
    Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
    Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
    J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.